PTC Therapeutics (NASDAQ:PTCT) Cut to Sell at Citigroup
Citigroup downgraded shares of PTC Therapeutics (NASDAQ:PTCT – Free Report) from a neutral rating to a sell rating in a research note issued to investors on Friday morning, MarketBeat Ratings reports. Citigroup currently has $17.00 target price on the biopharmaceutical company’s stock, down from their previous target price of $29.00. Several other equities analysts have […]
More Stories
CCL Industries (TSE:CCL.B) Sets New 1-Year High at $74.56
CCL Industries Inc. (TSE:CCL.B – Get Free Report) hit a new 52-week high during trading on Wednesday . The company...
Pine Cliff Energy (TSE:PNE) Sets New 12-Month Low at $0.90
Shares of Pine Cliff Energy Ltd. (TSE:PNE – Get Free Report) hit a new 52-week low during trading on Wednesday...
Sernova (TSE:SVA) Reaches New 52-Week Low at $0.28
Sernova Corp. (TSE:SVA – Get Free Report)’s share price hit a new 52-week low during trading on Wednesday . The...
Cadence Bank Purchases 915 Shares of Tyson Foods, Inc. (NYSE:TSN)
Cadence Bank boosted its position in shares of Tyson Foods, Inc. (NYSE:TSN – Free Report) by 5.6% in the first...
Advisors Asset Management Inc. Acquires 413 Shares of O’Reilly Automotive, Inc. (NASDAQ:ORLY)
Advisors Asset Management Inc. lifted its position in O’Reilly Automotive, Inc. (NASDAQ:ORLY – Free Report) by 15.5% in the 1st...
Cadence Bank Cuts Holdings in The Goldman Sachs Group, Inc. (NYSE:GS)
Cadence Bank cut its holdings in The Goldman Sachs Group, Inc. (NYSE:GS – Free Report) by 10.4% during the first...